As a result of increasing concerns over falsified medicines, reimbursement fraud and theft throughout the pharmaceutical supply chain, by 2019 over 55 countries will have introduced serialisation and track and trace regulations. With varying legislation coming into force across the globe, understanding the requirements of the markets you operate in is of paramount importance.

Understanding the serialisation requirements of the markets you operate in is of paramount importance.

Failure to ensure you have a robust solution in place, which can comply with the new regulations in time, can result in production downtime, product wastage and a direct impact on reputation.

Our director of corporate projects, Staffan Widengren, discusses the complexities of serialisation with International Pharmaceutical Industry (IPI) magazine and highlights the various geographical, technical and financial considerations that pharmaceutical companies need think about when working with a contract partner.

Read the full article here

International Pharmaceutical Industry, Winter 2016 Issue 4